Profiles of individuals seeking psychiatric help for psychotic symptoms linked to methamphetamine abuse - Baseline results from the MAPS (methamphetamine and psychosis study)

Mental Health and Substance Use: Dual Diagnosis

Volumn 3, Issue 3, 2010, Pages 168-181

  Lecomte, Tania ^a,b   Mueser, Kim T ^c   MacEwan, William G ^d   Laferriere Simard, Marie Christine ^a   Thornton, Allen E ^e   Buchanan, Tari ^d   Goldner, Elliot ^e   Brink, Johann ^d   Ehmann, Tom S ^f   Lang, Donna ^d   Kang, Shimi ^d   Barr, Alasdair M ^d   Honer, William G ^d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b CENTRE DE RECHERCHE FERNAND SEGUIN   (Canada)

^c DARTMOUTH PSYCHIATRIC RESEARCH CENTER   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SIMON FRASER UNIVERSITY   (Canada)

^f Early Psychosis Intervention Program   (Canada)

Author keywords

comorbidity; methamphetamine; profile; psychosis; substance abuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; CANNABICHROMENE; CANNABIS; COCAINE; DIAMORPHINE; METHADONE; METHAMPHETAMINE; SEDATIVE AGENT;

ACCIDENT; ADULT; ALCOHOLISM; ARTICLE; ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; CHILD ABUSE; CHILDHOOD INJURY; CLINICAL ASSESSMENT; COMORBIDITY; DEPRESSION; DISASTER; DRUG DEPENDENCE; FAMILY HISTORY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MANIA; MENTAL DISEASE; MILITARY SERVICE; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; PSYCHOPATHY; PSYCHOSIS; SCHIZOPHRENIA; SEXUAL CRIME; SUBSTANCE ABUSE; SUICIDE; VIOLENCE;

EID: 77956915534     PISSN: 17523281     EISSN: 17523273     Source Type: Journal    
DOI: 10.1080/17523281.2010.504645     Document Type: Article

References (45)

1. Anglin, M.D., Burke, C., Perrochet, B., Stamper, E., & Dawud-Noursi, S. (2000). History of the methamphetamine problem. Journal of Psychoactive Drugs, 32, 137-141.
2. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV. Washington, DC: American Psychaitric Association.
3. Barr, A.M., Panenka, W.J., MacEwan, G.W., Thornton, A.E., Lang, D.M., Honer, W.G., et al. (2006). The need for speed: An update on methamphetamine addiction. Journal of Psychiatry and Neuroscience, 31, 301-313.
4. Bayoumi, A.M., & Hwang, S.W. (2002). Methodological, practical, and ethical challenges to inner-city health research. Journal of Urban Health, 79(suppl. 1), s35-s42.
5. Beck, A.T., Steer, R.A., Ball, R., & Ranieri, W. (1996). Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment, 67, 588-597.
6. Blanchard, E.P., Jones-Alexander, J., Buckley, T.C., & Forneris, C.A. (1996). Psychometric properties of the PTSD Checklist. Behavior Therapy, 34, 669-673.
7. Caton, C.L.M., Drake, R., Hasin, D.S., Dominguez, B., Shrout, P.E., Samet, S., et al. (2005). Differences between early-phase primary psychotic disorders with concurrent substance use and substance-induced psychoses. Archives of General Psychiatry, 62, 137-145.
8. Drake, R., Mercer-McFadden, C., Mueser, K.T., McHugo, G., & Bond, G.R. (1998). Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophrenia Bulletin, 24, 589-607.
9. Drake, R.E., Wallach, M.A., Alverson, H., & Mueser, K.T. (2002). Psychosocial aspects of substance abuse by clients with severe mental illness. The Journal of Nervous and Mental Disease, 190, 100-106.
10. First, M.B., Spitzer, R.L., Gibbon, M., & Williams, J.B.W. (1997). Structured Clinical Interview for DSM IVAxis I and II disorders-Patient edition. New York, NY: Biometrics Research Department.
11. Frame, L., & Morrison, A.P. (2001). Causes of posttraumatic stress disorder in psychotic patients. Archives of General Psychiatry, 58, 305-306.
12. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2008). Identifying methamphetamine users at risk for major depressive disorder: Findings from the Methamphetamine Treatment Project at three-year follow-up. The American Journal on Addictions, 17, 99-102.
13. Grelotti, D.J., Kanayama, G., & Pope, H.G. (2010). Remission of persistent methamphetamine- induced psychosis after electroconvulsive therapy: Presentation of a case and review of the literature. American Journal of Psychiatry, 167, 17-23.
14. Hair, J.F., Anderson, R.E., Tatham, R.L., & Black, W.C. (1998). Multivariate data analysis with readings (5th ed.). Englewood Cliffs, NJ: Prentice Hall.
15. Janowsky, D.S., & Davis, J.M. (1976). Methylphenidate, dextroamphetamine, and levamphetamine. Archives of General Psychiatry, 33, 304-308.
16. Kay, S.R., Fiszbein, A., & Opler, L.A. (1987). The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin, 13, 261-276.
17. Lieberman, J.A., Kane, J.M., & Alvir, J. (1987). Provocative tests with psychostimulant drugs in schizophrenia. Psychopharmacology, 91, 415-433.
18. Mahoney, J.J., Kalechstein, A.D., De La Garza, R., & Newton, T.F. (2008). Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants. The American Journal on Addictions, 17, 83-98.
19. MARC. (2002, November 28). Methamphetamine Environmental Scan Summit-Final Report
20. Richmond, BC. McGovern, M.P., Lambert-Harris, C., Acquilano, S., Weiss, R.D., & Xie, H. (2009). A cognitive behavioral therapy for co-occurring substance use and posttraumatic stress disorders. Addictive Behaviors, 34, 892-897.
21. McKetin, R., McLaren, J., Lubman, D.I., & Hides, L. (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction, 101, 1473-1478.
22. Messina, N., Marinelli-Casey, P., Hillhouse, M., Rawson, R., Hunter, J., & Ang, A. (2008). Childhood adverse events and methamphetamine use among men and women. Journal of Psychoactive Drugs, Suppl 5, 399-409.
23. Mueser, K.T., Drake, R., & Wallach, M.A. (1998). Dual diagnosis: A review of etiological theories. Addictive Behaviors, 23, 717-734.
24. Mueser, K.T., Frisman, L.B., Drake, R., Covell, N.H., & Essock, S.M. (2006). Conduct disorder and antisocial personality disorder in persons with severe psychiatric and substance use disorders. Schizophrenia Bulletin, 32, 626-636.
25. Mueser, K.T., Noordsy, D.L., Drake, R.E., & Fox, L.B. (2003). Integrated treatment for dual disorders-A guide to effective practice. New York, NY: The Guilford Press.
26. Mueser, K.T., Rosenberg, S.D., Goodman, L.A., & Trumbetta, S.L. (2002). Trauma, PTSD, and the course of severe mental illness: an interactive model. Schizophrenia Research, 53, 123-143.
27. Mueser, K.T., Salyers, M.P., Rosenberg, S.D., Ford, J.D., Fox, L., & Cardy, P. (2001). A psychometric evaluation of trauma and PTSD assessments in persons with severe mental illness. Psychological Assessment, 13, 110-117.
28. Najavits, L.M., Ryngala, D., Back, S.E., Bolton, E.E., Mueser, K.T., & Brady, E.T. (2009). Treatment of PTSD and comorbid disorders. In E.B. Foa, T.M. Keane, M.J. Friedman & J.A. Cohen (Eds.), Treatments for PTSD: Practice guidelines from the International Society for Traumatic Stress Studies (2nd ed., pp. 508-535). New York, NY: Guilford Press.
29. Raimo, E.B., Smith, T.L., Danko, G.P., Bucholz, K.K., & Schuckit, M.A. (2000). Clinical characteristics and family histories of alcoholics with stimulant dependence. Journal of Studies on Alcohol, 61, 728-735.
30. Rawson, R., Gonzales, R., & Brethen, P. (2002a). Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment, 23, 145-150.
31. Rawson, R.A., Anglin, M.D., & Ling, W. (2002b). Will the methamphetamine problem go away? Journal of Addictive Diseases, 21, 5-19.
32. Rosenberg, H.J., Lu, W., Mueser, K.T., Jankowski, M.K., & Cournos, F. (2007). Correlates of adverse childhood events among adults with schizophrenia spectrum disorders. Psychiatric Services, 58, 245-253.
33. Ruiz, M.A., Pincus, A.L., & Schinka, J.A. (2008). Externalizing pathology and the Five-Factor Model: A meta-analysis of personality traits associated with antisocial personality disorder, substance use disorder, and their co-occurrence. Journal of Personality Disorders, 22, 365-388.
34. Schnurr, P.P., Vielhauer, M.J., Weathers, F., & Findler, M. (1999). The Brief Trauma Questionnaire. White River Junction, VT: National Center for PTSD.
35. Sim, T., Simon, S.L., Domier, C.P., Richardson, K., Rawson, R.A., & Ling, W. (2002). Cognitive deficits among methamphetamine users with attention deficit hyperactivity disorder symptomatology. Journal of Addiction Disorders, 21, 75-89.
36. Sobell, M.B., Maisto, S.A., Sobell, L.C., Copper, A.M., & Sanders, B. (1980). Developing a prototype for evaluating alcohol treatment effectiveness. In L.C. Sobell, M.B. Sobell & E. Ward (Eds.), Evaluating alcohol and drug abuse treatment effectiveness (pp. 129-150). New York, NY: Pergamon Press.
37. Stewart, S.H., Pihl, R.O., Conrod, P.J., & Dongier, M. (1998). Functional associations among trauma, PTSD, and substance-related disorders. Addictive Behaviors, 6, 797-812.
38. Tsuang, M.T. (1994). Genetics, epidemiology, and the search for causes of schizophrenia. American Journal of Psychiatry, 151, 3-6.
39. Ujike, H., & Sato, M. (2004). Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis. Annals of the New York Academy of Sciences, 1025, 279-287.
40. United Nations Office on Drugs and Crime. (2009). World drug report 2009. New York, NY: UNODC.
41. Ventura, J., Green, M., Shaner, A., & Liberman, R.P. (1993). Training and quality assurance with the Brief Psychiatric Rating Scale. International Journal of Methods in Psychiatric Research, 3, 221-244.
42. Yui, K., Ikemoto, S., Goto, K., Nishijima, K., Yoshino, T., & Ishiguro, T. (2002a). Spontaneous recurrence of methamphetamine-induced paranoid-hallucinatory states in female subjects: Susceptibility to psychotic states and implications for relapse of schizophrenia. Pharmacopsychiatry, 35, 62-71.
43. Yui, K., Ikemoto, S., Ishiguro, T., & Goto, K. (2002b). Factors for susceptibility to episode recurrence in spontaneous recurrence of methamphetamine psychosis. Annals of the New York Academy of Sciences, 965, 292-304.
44. Zanis, D.A., McLellan, A., & Thomas, C.S. (1997). Is the Addiction Severity Index a reliable and valid assessment instrument among clients with severe and persistent mental illness and substance abuse disorders? Community Mental Health Journal, 33, 213-227.
45. Zweben, J.E., Cohen, J.B., Christian, D., Galloway, G.P., Salinardi, M., Parent, D., et al. (2004). Psychiatric dymptoms in methamphetamine users. The American Journal on Addictions, 13, 181-190.